GAPLINC and breast cancer: It has been shown that miR-378 regulates proliferation and cell cycle progression of gastric cancer cells by targeting GAPLINC lncRNA whereas modulates apoptosis by interacting with GAS5 lncRNA in breast cancer (32, 33).